Pediatric intestinal Behçet disease complicated by myeloid malignancies

Behçet disease (BD) is rarely seen in children. Its clinical manifestations are believed to differ between pediatric and adult patients. The characteristics of BD complicated by myelodysplastic syndrome (MDS) are well established for adult patients; however, because only a few cases of pediatric-ons...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology 2017-03, Vol.105 (3), p.377-382
Main Authors: Kanamitsu, Kiichiro, Shimada, Akira, Nishiuchi, Ritsuo, Shigemura, Tomonari, Nakazawa, Yozo, Koike, Kenichi, Kodama, Yuichi, Shinkoda, Yuichi, Kawano, Yoshifumi, Yasui, Kozo, Sasaki, Koji, Kajiwara, Ryosuke, Tsukahara, Hirokazu, Manabe, Atsushi
Format: Article
Language:English
Subjects:
Antineoplastic Agents - therapeutic use
Behcet Syndrome - complications
Behcet Syndrome - therapy
Child
Child, Preschool
Female
Hematology
Hematopoietic Stem Cell Transplantation
Humans
Intestinal Diseases - complications
Intestinal Diseases - therapy
Japan
Leukemia, Myeloid, Acute - complications
Leukemia, Myeloid, Acute - therapy
Medicine
Medicine & Public Health
Myelodysplastic Syndromes - complications
Myelodysplastic Syndromes - therapy
Oncology
Original Article
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Behçet disease (BD) is rarely seen in children. Its clinical manifestations are believed to differ between pediatric and adult patients. The characteristics of BD complicated by myelodysplastic syndrome (MDS) are well established for adult patients; however, because only a few cases of pediatric-onset BD complicated by MDS have been reported, its clinical characteristics remain unknown. We here retrospectively review pediatric-onset BD complicated by myeloid malignancies in Japan, having identified five such patients. All patients were female and had gastrointestinal involvements, but lacked both major features of BD, i.e., uveitis and association with HLA-B51. All patients had advanced MDS or acute myeloid leukemia and received chemotherapy followed by hematopoietic stem cell transplantation. These five cases suggest that intestinal BD and myeloid malignancies have one or more pathophysiological mechanisms in common.
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-016-2127-7